ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Generic Sterile Injectable - Global Market Insights and Sales Trends 2024
Published Date: November 2023
|
Report Code: QYRE-Auto-39R6756
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Generic Sterile Injectable Market Insights and Forecast to 2028
BUY CHAPTERS

Generic Sterile Injectable - Global Market Insights and Sales Trends 2024

Code: QYRE-Auto-39R6756
Report
November 2023
Pages:103
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
3M
Baxter
Fresenius Kabi
Pfizer (Hospira)
Novartis (Sandoz)
TEVA
Hikma
Sun Pharma
Dr. Reddy's
Mylan NV
Astrazeneca plc
Merck& Co. Inc
Hellberg Safety Ab

Generic Sterile Injectable - Market Size

The global Generic Sterile Injectable market size is expected to reach US$ 78570 million by 2029, growing at a CAGR of 5.8% from 2023 to 2029.

Generic Sterile Injectable - Market

Generic Sterile Injectable - Market

The generic sterile injectable are FDA approved biologics that are used for the treatment of many diseases and disorders in the vast arena of the healthcare industry. The generic sterile injectable are very inexpensive as compared to that of their branded counterparts of these drugs and performs equally well. Thus, these Injectables are heavily in demand all the time and are used in majority of hospitals and clinics across the globe. However, due to the stringent FDA regulations for the production of these injectable, the rigorous demand satisfaction of these injectable has always been a constant challenge for the key players in the global generic sterile injectable market.
The generic sterile injectable market is expected to gain steady traction in the foreseeable future as the sterile injectable products find its application across a wide number of diseases and medical condition. Manufacturers are focused on increasing the production of generic sterile injectable to meet the rising demands without compromising on the quality of the injectable.
The market is mainly driven by the significant applications of Generic Sterile Injectable in various end use industries. The expanding demands from the Hospitals, Pharmacies and Online Pharmacies,, are propelling Generic Sterile Injectable market. Monoclonal Antibodies, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Cytokines segment is estimated at % CAGR for the next seven-year period.
An alternative to the oral delivery mechanism is injectable drug delivery, which easily transports a drug dose through the bloodstream, thereby bypassing first-pass metabolism. There are some medications that would be entirely useless if delivered as capsules, as they would be killed by enzymes that digest food in the stomach. The insulin injection used in diabetes care is an example. Insulin is a protein. Therefore, if given as a tablet, the same enzymes that ferment food in the stomach would be digested. Therefore, as of today, there is no such term as an insulin tablet. Injectable allow the transport, directly into the bloodstream, of drugs manufactured in liquid form. The goal of the delivery of injectable drugs is to optimize patient compliance and reduce the frequency of dose administration without reducing medication efficacy. Due to deep vomiting, unconsciousness or having a cancer lining in the upper part of their dietary canal, it may be impossible to take tablets for certain patients. Therefore, injection options are available for most oral medications. The increasing prevalence of such metabolic disease aids in the overall growth in the sterile injectable market.

Report Objectives

This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Generic Sterile Injectable, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Generic Sterile Injectable market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Generic Sterile Injectable market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Generic Sterile Injectable sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Generic Sterile Injectable covered in this report include 3M, Baxter Inc, Fresenius Kabi, Pfizer/Hospira, Novartis/Sandoz, Teva, Hikma, Sun Pharma and Dr. Reddy’s, etc.
The global Generic Sterile Injectable market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
3M
Baxter Inc
Fresenius Kabi
Pfizer/Hospira
Novartis/Sandoz
Teva
Hikma
Sun Pharma
Dr. Reddy’s
Mylan
AstraZeneca Plc
Merck & Co., Inc
Hellberg Safety Ab

Scope of Generic Sterile Injectable - Market Report

Report Metric Details
Report Name Generic Sterile Injectable - Market
Forecasted market size in 2029 US$ 78570 million
CAGR 5.8%
Forecasted years 2023 - 2029
Global Generic Sterile Injectable market, by region:
  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Generic Sterile Injectable market, Segment by Type:
  • Monoclonal Antibodies
  • Cytokines
  • Insulin
  • Peptide Hormones
  • Vaccines
  • Others
Global Generic Sterile Injectable market, by Application
  • Hospitals
  • Pharmacies
  • Online Pharmacies
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
  • Chapter Two: Detailed analysis of Generic Sterile Injectable manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter Three: Sales, revenue of Generic Sterile Injectable in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
  • Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
  • Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
  • Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter Twelve: Analysis of sales channel, distributors and customers.
  • Chapter Thirteen: Research Findings and Conclusion.

FAQ for this report

What is the Generic Sterile Injectable - Market size in 2029?

Ans: The Generic Sterile Injectable - Market size in 2029 will be US$ 78570 million.

What are the Application segmentation covered in the Generic Sterile Injectable - Market report?

Ans: The Applications covered in the Generic Sterile Injectable - Market report are Hospitals, Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Generic Sterile Injectable - Market report?

Ans: The Types covered in the Generic Sterile Injectable - Market report are Monoclonal Antibodies, Cytokines, Insulin, Peptide Hormones, Vaccines, Others

1 Generic Sterile Injectable Market Overview
1.1 Generic Sterile Injectable Product Overview
1.2 Generic Sterile Injectable Market Segment by Type
1.2.1 Monoclonal Antibodies
1.2.2 Cytokines
1.2.3 Insulin
1.2.4 Peptide Hormones
1.2.5 Vaccines
1.2.6 Others
1.3 Global Generic Sterile Injectable Market Size by Type
1.3.1 Global Generic Sterile Injectable Market Size Overview by Type (2018-2029)
1.3.2 Global Generic Sterile Injectable Historic Market Size Review by Type (2018-2023)
1.3.3 Global Generic Sterile Injectable Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Generic Sterile Injectable Sales Breakdown by Type (2018-2023)
1.4.2 Europe Generic Sterile Injectable Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Generic Sterile Injectable Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Generic Sterile Injectable Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Generic Sterile Injectable Sales Breakdown by Type (2018-2023)
2 Global Generic Sterile Injectable Market Competition by Company
2.1 Global Top Players by Generic Sterile Injectable Sales (2018-2023)
2.2 Global Top Players by Generic Sterile Injectable Revenue (2018-2023)
2.3 Global Top Players by Generic Sterile Injectable Price (2018-2023)
2.4 Global Top Manufacturers Generic Sterile Injectable Manufacturing Base Distribution, Sales Area, Product Type
2.5 Generic Sterile Injectable Market Competitive Situation and Trends
2.5.1 Generic Sterile Injectable Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Generic Sterile Injectable Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Generic Sterile Injectable as of 2022)
2.7 Date of Key Manufacturers Enter into Generic Sterile Injectable Market
2.8 Key Manufacturers Generic Sterile Injectable Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Generic Sterile Injectable Status and Outlook by Region
3.1 Global Generic Sterile Injectable Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Generic Sterile Injectable Historic Market Size by Region
3.2.1 Global Generic Sterile Injectable Sales in Volume by Region (2018-2023)
3.2.2 Global Generic Sterile Injectable Sales in Value by Region (2018-2023)
3.2.3 Global Generic Sterile Injectable Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Generic Sterile Injectable Forecasted Market Size by Region
3.3.1 Global Generic Sterile Injectable Sales in Volume by Region (2024-2029)
3.3.2 Global Generic Sterile Injectable Sales in Value by Region (2024-2029)
3.3.3 Global Generic Sterile Injectable Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Generic Sterile Injectable by Application
4.1 Generic Sterile Injectable Market Segment by Application
4.1.1 Hospitals
4.1.2 Pharmacies
4.1.3 Online Pharmacies
4.2 Global Generic Sterile Injectable Market Size by Application
4.2.1 Global Generic Sterile Injectable Market Size Overview by Application (2018-2029)
4.2.2 Global Generic Sterile Injectable Historic Market Size Review by Application (2018-2023)
4.2.3 Global Generic Sterile Injectable Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Generic Sterile Injectable Sales Breakdown by Application (2018-2023)
4.3.2 Europe Generic Sterile Injectable Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Generic Sterile Injectable Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Generic Sterile Injectable Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Generic Sterile Injectable Sales Breakdown by Application (2018-2023)
5 North America Generic Sterile Injectable by Country
5.1 North America Generic Sterile Injectable Historic Market Size by Country
5.1.1 North America Generic Sterile Injectable Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Generic Sterile Injectable Sales in Volume by Country (2018-2023)
5.1.3 North America Generic Sterile Injectable Sales in Value by Country (2018-2023)
5.2 North America Generic Sterile Injectable Forecasted Market Size by Country
5.2.1 North America Generic Sterile Injectable Sales in Volume by Country (2024-2029)
5.2.2 North America Generic Sterile Injectable Sales in Value by Country (2024-2029)
6 Europe Generic Sterile Injectable by Country
6.1 Europe Generic Sterile Injectable Historic Market Size by Country
6.1.1 Europe Generic Sterile Injectable Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Generic Sterile Injectable Sales in Volume by Country (2018-2023)
6.1.3 Europe Generic Sterile Injectable Sales in Value by Country (2018-2023)
6.2 Europe Generic Sterile Injectable Forecasted Market Size by Country
6.2.1 Europe Generic Sterile Injectable Sales in Volume by Country (2024-2029)
6.2.2 Europe Generic Sterile Injectable Sales in Value by Country (2024-2029)
7 Asia-Pacific Generic Sterile Injectable by Region
7.1 Asia-Pacific Generic Sterile Injectable Historic Market Size by Region
7.1.1 Asia-Pacific Generic Sterile Injectable Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Generic Sterile Injectable Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Generic Sterile Injectable Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Generic Sterile Injectable Forecasted Market Size by Region
7.2.1 Asia-Pacific Generic Sterile Injectable Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Generic Sterile Injectable Sales in Value by Region (2024-2029)
8 Latin America Generic Sterile Injectable by Country
8.1 Latin America Generic Sterile Injectable Historic Market Size by Country
8.1.1 Latin America Generic Sterile Injectable Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Generic Sterile Injectable Sales in Volume by Country (2018-2023)
8.1.3 Latin America Generic Sterile Injectable Sales in Value by Country (2018-2023)
8.2 Latin America Generic Sterile Injectable Forecasted Market Size by Country
8.2.1 Latin America Generic Sterile Injectable Sales in Volume by Country (2024-2029)
8.2.2 Latin America Generic Sterile Injectable Sales in Value by Country (2024-2029)
9 Middle East and Africa Generic Sterile Injectable by Country
9.1 Middle East and Africa Generic Sterile Injectable Historic Market Size by Country
9.1.1 Middle East and Africa Generic Sterile Injectable Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Generic Sterile Injectable Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Generic Sterile Injectable Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Generic Sterile Injectable Forecasted Market Size by Country
9.2.1 Middle East and Africa Generic Sterile Injectable Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Generic Sterile Injectable Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 3M
10.1.1 3M Company Information
10.1.2 3M Introduction and Business Overview
10.1.3 3M Generic Sterile Injectable Sales, Revenue and Gross Margin (2018-2023)
10.1.4 3M Generic Sterile Injectable Products Offered
10.1.5 3M Recent Development
10.2 Baxter Inc
10.2.1 Baxter Inc Company Information
10.2.2 Baxter Inc Introduction and Business Overview
10.2.3 Baxter Inc Generic Sterile Injectable Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Baxter Inc Generic Sterile Injectable Products Offered
10.2.5 Baxter Inc Recent Development
10.3 Fresenius Kabi
10.3.1 Fresenius Kabi Company Information
10.3.2 Fresenius Kabi Introduction and Business Overview
10.3.3 Fresenius Kabi Generic Sterile Injectable Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Fresenius Kabi Generic Sterile Injectable Products Offered
10.3.5 Fresenius Kabi Recent Development
10.4 Pfizer/Hospira
10.4.1 Pfizer/Hospira Company Information
10.4.2 Pfizer/Hospira Introduction and Business Overview
10.4.3 Pfizer/Hospira Generic Sterile Injectable Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Pfizer/Hospira Generic Sterile Injectable Products Offered
10.4.5 Pfizer/Hospira Recent Development
10.5 Novartis/Sandoz
10.5.1 Novartis/Sandoz Company Information
10.5.2 Novartis/Sandoz Introduction and Business Overview
10.5.3 Novartis/Sandoz Generic Sterile Injectable Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Novartis/Sandoz Generic Sterile Injectable Products Offered
10.5.5 Novartis/Sandoz Recent Development
10.6 Teva
10.6.1 Teva Company Information
10.6.2 Teva Introduction and Business Overview
10.6.3 Teva Generic Sterile Injectable Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Teva Generic Sterile Injectable Products Offered
10.6.5 Teva Recent Development
10.7 Hikma
10.7.1 Hikma Company Information
10.7.2 Hikma Introduction and Business Overview
10.7.3 Hikma Generic Sterile Injectable Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Hikma Generic Sterile Injectable Products Offered
10.7.5 Hikma Recent Development
10.8 Sun Pharma
10.8.1 Sun Pharma Company Information
10.8.2 Sun Pharma Introduction and Business Overview
10.8.3 Sun Pharma Generic Sterile Injectable Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Sun Pharma Generic Sterile Injectable Products Offered
10.8.5 Sun Pharma Recent Development
10.9 Dr. Reddy’s
10.9.1 Dr. Reddy’s Company Information
10.9.2 Dr. Reddy’s Introduction and Business Overview
10.9.3 Dr. Reddy’s Generic Sterile Injectable Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Dr. Reddy’s Generic Sterile Injectable Products Offered
10.9.5 Dr. Reddy’s Recent Development
10.10 Mylan
10.10.1 Mylan Company Information
10.10.2 Mylan Introduction and Business Overview
10.10.3 Mylan Generic Sterile Injectable Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Mylan Generic Sterile Injectable Products Offered
10.10.5 Mylan Recent Development
10.11 AstraZeneca Plc
10.11.1 AstraZeneca Plc Company Information
10.11.2 AstraZeneca Plc Introduction and Business Overview
10.11.3 AstraZeneca Plc Generic Sterile Injectable Sales, Revenue and Gross Margin (2018-2023)
10.11.4 AstraZeneca Plc Generic Sterile Injectable Products Offered
10.11.5 AstraZeneca Plc Recent Development
10.12 Merck & Co., Inc
10.12.1 Merck & Co., Inc Company Information
10.12.2 Merck & Co., Inc Introduction and Business Overview
10.12.3 Merck & Co., Inc Generic Sterile Injectable Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Merck & Co., Inc Generic Sterile Injectable Products Offered
10.12.5 Merck & Co., Inc Recent Development
10.13 Hellberg Safety Ab
10.13.1 Hellberg Safety Ab Company Information
10.13.2 Hellberg Safety Ab Introduction and Business Overview
10.13.3 Hellberg Safety Ab Generic Sterile Injectable Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Hellberg Safety Ab Generic Sterile Injectable Products Offered
10.13.5 Hellberg Safety Ab Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Generic Sterile Injectable Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Generic Sterile Injectable Industrial Chain Analysis
11.4 Generic Sterile Injectable Market Dynamics
11.4.1 Generic Sterile Injectable Industry Trends
11.4.2 Generic Sterile Injectable Market Drivers
11.4.3 Generic Sterile Injectable Market Challenges
11.4.4 Generic Sterile Injectable Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Generic Sterile Injectable Distributors
12.3 Generic Sterile Injectable Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
3M
Baxter
Fresenius Kabi
Pfizer (Hospira)
Novartis (Sandoz)
TEVA
Hikma
Sun Pharma
Dr. Reddy's
Mylan NV
Astrazeneca plc
Merck& Co. Inc
Hellberg Safety Ab
List of Tables
    Table 1. Major Company of Monoclonal Antibodies
    Table 2. Major Company of Cytokines
    Table 3. Major Company of Insulin
    Table 4. Major Company of Peptide Hormones
    Table 5. Major Company of Vaccines
    Table 6. Major Company of Others
    Table 7. Global Generic Sterile Injectable Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
    Table 8. Global Generic Sterile Injectable Sales by Type (2018-2023) & (K Units)
    Table 9. Global Generic Sterile Injectable Sales Market Share in Volume by Type (2018-2023)
    Table 10. Global Generic Sterile Injectable Sales by Type (2018-2023) & (US& Million)
    Table 11. Global Generic Sterile Injectable Market Share in Value by Type (2018-2023)
    Table 12. Global Generic Sterile Injectable Price by Type (2018-2023) & (USD/Unit)
    Table 13. Global Generic Sterile Injectable Sales by Type (2024-2029) & (K Units)
    Table 14. Global Generic Sterile Injectable Sales Market Share in Volume by Type (2024-2029)
    Table 15. Global Generic Sterile Injectable Sales by Type (2024-2029) & (US$ Million)
    Table 16. Global Generic Sterile Injectable Sales Market Share in Value by Type (2024-2029)
    Table 17. Global Generic Sterile Injectable Price by Type (2024-2029) & (USD/Unit)
    Table 18. North America Generic Sterile Injectable Sales by Type (2018-2023) & (K Units)
    Table 19. North America Generic Sterile Injectable Sales by Type (2018-2023) & (US$ Million)
    Table 20. Europe Generic Sterile Injectable Sales (K Units) by Type (2018-2023)
    Table 21. Europe Generic Sterile Injectable Sales by Type (2018-2023) & (US$ Million)
    Table 22. Asia-Pacific Generic Sterile Injectable Sales (K Units) by Type (2018-2023)
    Table 23. Asia-Pacific Generic Sterile Injectable Sales by Type (2018-2023) & (US$ Million)
    Table 24. Latin America Generic Sterile Injectable Sales (K Units) by Type (2018-2023)
    Table 25. Latin America Generic Sterile Injectable Sales by Type (2018-2023) & (US$ Million)
    Table 26. Middle East and Africa Generic Sterile Injectable Sales (K Units) by Type (2018-2023)
    Table 27. Middle East and Africa Generic Sterile Injectable Sales by Type (2018-2023) & (US$ Million)
    Table 28. Global Generic Sterile Injectable Sales by Company (2018-2023) & (K Units)
    Table 29. Global Generic Sterile Injectable Sales Share by Company (2018-2023)
    Table 30. Global Generic Sterile Injectable Revenue by Company (2018-2023) & (US$ Million)
    Table 31. Global Generic Sterile Injectable Revenue Share by Company (2018-2023)
    Table 32. Global Market Generic Sterile Injectable Price by Company (2018-2023) & (USD/Unit)
    Table 33. Global Generic Sterile Injectable Top Manufacturers Manufacturing Base Distribution and Sales Area
    Table 34. Global Generic Sterile Injectable Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 35. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Generic Sterile Injectable as of 2022)
    Table 36. Date of Key Manufacturers Enter into Generic Sterile Injectable Market
    Table 37. Key Manufacturers Generic Sterile Injectable Product Type
    Table 38. Mergers & Acquisitions, Expansion Plans
    Table 39. Global Generic Sterile Injectable Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 40. Global Generic Sterile Injectable Sales by Region (2018-2023) & (K Units)
    Table 41. Global Generic Sterile Injectable Sales Market Share in Volume by Region (2018-2023)
    Table 42. Global Generic Sterile Injectable Sales by Region (2018-2023) & (US$ Million)
    Table 43. Global Generic Sterile Injectable Sales Market Share in Value by Region (2018-2023)
    Table 44. Global Generic Sterile Injectable Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 45. Global Generic Sterile Injectable Sales by Region (2024-2029) & (K Units)
    Table 46. Global Generic Sterile Injectable Sales Market Share in Volume by Region (2024-2029)
    Table 47. Global Generic Sterile Injectable Sales by Region (2024-2029) & (US$ Million)
    Table 48. Global Generic Sterile Injectable Sales Market Share in Value by Region (2024-2029)
    Table 49. Global Generic Sterile Injectable Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2029)
    Table 50. Global Generic Sterile Injectable Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 51. Global Generic Sterile Injectable Sales by Application (2018-2023) & (K Units)
    Table 52. Global Generic Sterile Injectable Sales Market Share in Volume by Application (2018-2023)
    Table 53. Global Generic Sterile Injectable Sales by Application (2018-2023) & (US$ Million)
    Table 54. Global Generic Sterile Injectable Sales Market Share in Value by Application (2018-2023)
    Table 55. Global Generic Sterile Injectable Price by Application (2018-2023) & (USD/Unit)
    Table 56. Global Generic Sterile Injectable Sales by Application (2024-2029) & (K Units)
    Table 57. Global Generic Sterile Injectable Sales Market Share in Volume by Application (2024-2029)
    Table 58. Global Generic Sterile Injectable Sales by Application (2024-2029) & (US$ Million)
    Table 59. Global Generic Sterile Injectable Sales Market Share in Value by Application (2024-2029)
    Table 60. Global Generic Sterile Injectable Price by Application (2024-2029) & (USD/Unit)
    Table 61. North America Generic Sterile Injectable Sales by Application (2018-2023) (K Units)
    Table 62. North America Generic Sterile Injectable Sales by Application (2018-2023) & (US$ Million)
    Table 63. Europe Generic Sterile Injectable Sales by Application (2018-2023) (K Units)
    Table 64. Europe Generic Sterile Injectable Sales by Application (2018-2023) & (US$ Million)
    Table 65. Asia-Pacific Generic Sterile Injectable Sales by Application (2018-2023) (K Units)
    Table 66. Asia-Pacific Generic Sterile Injectable Sales by Application (2018-2023) & (US$ Million)
    Table 67. Latin America Generic Sterile Injectable Sales by Application (2018-2023) (K Units)
    Table 68. Latin America Generic Sterile Injectable Sales by Application (2018-2023) & (US$ Million)
    Table 69. Middle East and Africa Generic Sterile Injectable Sales by Application (2018-2023) (K Units)
    Table 70. Middle East and Africa Generic Sterile Injectable Sales by Application (2018-2023) & (US$ Million)
    Table 71. North America Generic Sterile Injectable Sales by Country (2018-2023) & (K Units)
    Table 72. North America Generic Sterile Injectable Sales Market Share in Volume by Country (2018-2023)
    Table 73. North America Generic Sterile Injectable Sales by Country (2018-2023) & (US$ Million)
    Table 74. North America Generic Sterile Injectable Sales Market Share in Value by Country (2018-2023)
    Table 75. North America Generic Sterile Injectable Sales by Country (2024-2029) & (K Units)
    Table 76. North America Generic Sterile Injectable Sales Market Share in Volume by Country (2024-2029)
    Table 77. North America Generic Sterile Injectable Sales by Country (2024-2029) & (US$ Million)
    Table 78. North America Generic Sterile Injectable Sales Market Share in Value by Country (2024-2029)
    Table 79. Europe Generic Sterile Injectable Sales by Country (2018-2023) & (K Units)
    Table 80. Europe Generic Sterile Injectable Sales Market Share in Volume by Country (2018-2023)
    Table 81. Europe Generic Sterile Injectable Sales by Country (2018-2023) & (US$ Million)
    Table 82. Europe Generic Sterile Injectable Sales Market Share in Value by Country (2018-2023)
    Table 83. Europe Generic Sterile Injectable Sales by Country (2024-2029) & (K Units)
    Table 84. Europe Generic Sterile Injectable Sales Market Share in Volume by Country (2024-2029)
    Table 85. Europe Generic Sterile Injectable Sales by Country (2024-2029) & (US$ Million)
    Table 86. Europe Generic Sterile Injectable Sales Market Share in Value by Country (2024-2029)
    Table 87. Asia-Pacific Generic Sterile Injectable Sales by Region (2018-2023) & (K Units)
    Table 88. Asia-Pacific Generic Sterile Injectable Sales Market Share in Volume by Region (2018-2023)
    Table 89. Asia-Pacific Generic Sterile Injectable Sales by Region (2018-2023) & (US$ Million)
    Table 90. Asia-Pacific Generic Sterile Injectable Sales Market Share in Value by Region (2018-2023)
    Table 91. Asia-Pacific Generic Sterile Injectable Sales by Region (2024-2029) & (K Units)
    Table 92. Asia-Pacific Generic Sterile Injectable Sales Market Share in Volume by Region (2024-2029)
    Table 93. Asia-Pacific Generic Sterile Injectable Sales by Region (2024-2029) & (US$ Million)
    Table 94. Asia-Pacific Generic Sterile Injectable Sales Market Share in Value by Region (2024-2029)
    Table 95. Latin America Generic Sterile Injectable Sales by Country (2018-2023) & (K Units)
    Table 96. Latin America Generic Sterile Injectable Sales Market Share in Volume by Country (2018-2023)
    Table 97. Latin America Generic Sterile Injectable Sales by Country (2018-2023) & (US$ Million)
    Table 98. Latin America Generic Sterile Injectable Sales Market Share in Value by Country (2018-2023)
    Table 99. Latin America Generic Sterile Injectable Sales by Country (2024-2029) & (K Units)
    Table 100. Latin America Generic Sterile Injectable Sales Market Share in Volume by Country (2024-2029)
    Table 101. Latin America Generic Sterile Injectable Sales by Country (2024-2029) & (US$ Million)
    Table 102. Latin America Generic Sterile Injectable Sales Market Share in Value by Country (2024-2029)
    Table 103. Middle East and Africa Generic Sterile Injectable Sales by Country (2018-2023) & (K Units)
    Table 104. Middle East and Africa Generic Sterile Injectable Sales Market Share in Volume by Country (2018-2023)
    Table 105. Middle East and Africa Generic Sterile Injectable Sales by Country (2018-2023) & (US$ Million)
    Table 106. Middle East and Africa Generic Sterile Injectable Sales Market Share in Value by Country (2018-2023)
    Table 107. Middle East and Africa Generic Sterile Injectable Sales by Country (2024-2029) & (K Units)
    Table 108. Middle East and Africa Generic Sterile Injectable Sales Market Share in Volume by Country (2024-2029)
    Table 109. Middle East and Africa Generic Sterile Injectable Sales by Country (2024-2029) & (US$ Million)
    Table 110. Middle East and Africa Generic Sterile Injectable Sales Market Share in Value by Country (2024-2029)
    Table 111. 3M Company Information
    Table 112. 3M Introduction and Business Overview
    Table 113. 3M Generic Sterile Injectable Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 114. 3M Generic Sterile Injectable Product
    Table 115. 3M Recent Development
    Table 116. Baxter Inc Company Information
    Table 117. Baxter Inc Introduction and Business Overview
    Table 118. Baxter Inc Generic Sterile Injectable Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 119. Baxter Inc Generic Sterile Injectable Product
    Table 120. Baxter Inc Recent Development
    Table 121. Fresenius Kabi Company Information
    Table 122. Fresenius Kabi Introduction and Business Overview
    Table 123. Fresenius Kabi Generic Sterile Injectable Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 124. Fresenius Kabi Generic Sterile Injectable Product
    Table 125. Fresenius Kabi Recent Development
    Table 126. Pfizer/Hospira Company Information
    Table 127. Pfizer/Hospira Introduction and Business Overview
    Table 128. Pfizer/Hospira Generic Sterile Injectable Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 129. Pfizer/Hospira Generic Sterile Injectable Product
    Table 130. Pfizer/Hospira Recent Development
    Table 131. Novartis/Sandoz Company Information
    Table 132. Novartis/Sandoz Introduction and Business Overview
    Table 133. Novartis/Sandoz Generic Sterile Injectable Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 134. Novartis/Sandoz Generic Sterile Injectable Product
    Table 135. Novartis/Sandoz Recent Development
    Table 136. Teva Company Information
    Table 137. Teva Introduction and Business Overview
    Table 138. Teva Generic Sterile Injectable Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 139. Teva Generic Sterile Injectable Product
    Table 140. Teva Recent Development
    Table 141. Hikma Company Information
    Table 142. Hikma Introduction and Business Overview
    Table 143. Hikma Generic Sterile Injectable Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 144. Hikma Generic Sterile Injectable Product
    Table 145. Hikma Recent Development
    Table 146. Sun Pharma Company Information
    Table 147. Sun Pharma Introduction and Business Overview
    Table 148. Sun Pharma Generic Sterile Injectable Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 149. Sun Pharma Generic Sterile Injectable Product
    Table 150. Sun Pharma Recent Development
    Table 151. Dr. Reddy’s Company Information
    Table 152. Dr. Reddy’s Introduction and Business Overview
    Table 153. Dr. Reddy’s Generic Sterile Injectable Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 154. Dr. Reddy’s Generic Sterile Injectable Product
    Table 155. Dr. Reddy’s Recent Development
    Table 156. Mylan Company Information
    Table 157. Mylan Introduction and Business Overview
    Table 158. Mylan Generic Sterile Injectable Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 159. Mylan Generic Sterile Injectable Product
    Table 160. Mylan Recent Development
    Table 161. AstraZeneca Plc Company Information
    Table 162. AstraZeneca Plc Introduction and Business Overview
    Table 163. AstraZeneca Plc Generic Sterile Injectable Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 164. AstraZeneca Plc Generic Sterile Injectable Product
    Table 165. AstraZeneca Plc Recent Development
    Table 166. Merck & Co., Inc Company Information
    Table 167. Merck & Co., Inc Introduction and Business Overview
    Table 168. Merck & Co., Inc Generic Sterile Injectable Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 169. Merck & Co., Inc Generic Sterile Injectable Product
    Table 170. Merck & Co., Inc Recent Development
    Table 171. Hellberg Safety Ab Company Information
    Table 172. Hellberg Safety Ab Introduction and Business Overview
    Table 173. Hellberg Safety Ab Generic Sterile Injectable Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 174. Hellberg Safety Ab Generic Sterile Injectable Product
    Table 175. Hellberg Safety Ab Recent Development
    Table 176. Key Raw Materials Lists
    Table 177. Raw Materials Key Suppliers Lists
    Table 178. Generic Sterile Injectable Market Trends
    Table 179. Generic Sterile Injectable Market Drivers
    Table 180. Generic Sterile Injectable Market Challenges
    Table 181. Generic Sterile Injectable Market Restraints
    Table 182. Generic Sterile Injectable Distributors List
    Table 183. Generic Sterile Injectable Downstream Customers
    Table 184. Research Programs/Design for This Report
    Table 185. Key Data Information from Secondary Sources
    Table 186. Key Data Information from Primary Sources
List of Figures
    Figure 1. Generic Sterile Injectable Product Picture
    Figure 2. Global Generic Sterile Injectable Market Size, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 3. Global Generic Sterile Injectable Market Size Status and Outlook (2018-2029) & (US$ Million)
    Figure 4. Global Generic Sterile Injectable Sales Status and Outlook (2018-2029) & (K Units)
    Figure 5. Product Picture of Monoclonal Antibodies
    Figure 6. Global Monoclonal Antibodies Sales YoY Growth (2018-2029) & (K Units)
    Figure 7. Product Picture of Cytokines
    Figure 8. Global Cytokines Sales YoY Growth (2018-2029) & (K Units)
    Figure 9. Product Picture of Insulin
    Figure 10. Global Insulin Sales YoY Growth (2018-2029) & (K Units)
    Figure 11. Product Picture of Peptide Hormones
    Figure 12. Global Peptide Hormones Sales YoY Growth (2018-2029) & (K Units)
    Figure 13. Product Picture of Vaccines
    Figure 14. Global Vaccines Sales YoY Growth (2018-2029) & (K Units)
    Figure 15. Product Picture of Others
    Figure 16. Global Others Sales YoY Growth (2018-2029) & (K Units)
    Figure 17. Global Generic Sterile Injectable Sales by Type (2018-2029) & (US$ Million)
    Figure 18. Global Generic Sterile Injectable Sales Market Share by Type in 2022 & 2029
    Figure 19. North America Generic Sterile Injectable Sales Market Share in Volume by Type in 2022
    Figure 20. North America Generic Sterile Injectable Sales Market Share in Value by Type in 2022
    Figure 21. Europe Generic Sterile Injectable Sales Market Share in Volume by Type in 2022
    Figure 22. Europe Generic Sterile Injectable Sales Market Share in Value by Type in 2022
    Figure 23. Asia-Pacific Generic Sterile Injectable Sales Market Share in Volume by Type in 2022
    Figure 24. Asia-Pacific Generic Sterile Injectable Sales Market Share in Value by Type in 2022
    Figure 25. Latin America Generic Sterile Injectable Sales Market Share in Volume by Type in 2022
    Figure 26. Latin America Generic Sterile Injectable Sales Market Share in Value by Type in 2022
    Figure 27. Middle East and Africa Generic Sterile Injectable Sales Market Share in Volume by Type in 2022
    Figure 28. Middle East and Africa Generic Sterile Injectable Sales Market Share in Value by Type in 2022
    Figure 29. The 5 and 10 Largest Manufacturers in the World: Market Share by Generic Sterile Injectable Sales in 2022
    Figure 30. The 5 and 10 Largest Manufacturers in the World: Market Share by Generic Sterile Injectable Revenue in 2022
    Figure 31. Generic Sterile Injectable Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
    Figure 32. Product Picture of Hospitals
    Figure 33. Global Hospitals Sales YoY Growth (2018-2029) & (K Units)
    Figure 34. Product Picture of Pharmacies
    Figure 35. Global Pharmacies Sales YoY Growth (2018-2029) & (K Units)
    Figure 36. Product Picture of Online Pharmacies
    Figure 37. Global Online Pharmacies Sales YoY Growth (2018-2029) & (K Units)
    Figure 38. Global Generic Sterile Injectable Sales by Application (2018-2029) & (US$ Million)
    Figure 39. Global Generic Sterile Injectable Sales Market Share by Application in 2022 & 2029
    Figure 40. North America Generic Sterile Injectable Sales Market Share in Volume by Application in 2022
    Figure 41. North America Generic Sterile Injectable Sales Market Share in Value by Application in 2022
    Figure 42. Europe Generic Sterile Injectable Sales Market Share in Volume by Application in 2022
    Figure 43. Europe Generic Sterile Injectable Sales Market Share in Value by Application in 2022
    Figure 44. Asia-Pacific Generic Sterile Injectable Sales Market Share in Volume by Application in 2022
    Figure 45. Asia-Pacific Generic Sterile Injectable Sales Market Share in Value by Application in 2022
    Figure 46. Latin America Generic Sterile Injectable Sales Market Share in Volume by Application in 2022
    Figure 47. Latin America Generic Sterile Injectable Sales Market Share in Value by Application in 2022
    Figure 48. Middle East and Africa Generic Sterile Injectable Sales Market Share in Value by Application in 2022
    Figure 49. Key Raw Materials Price
    Figure 50. Generic Sterile Injectable Manufacturing Cost Structure
    Figure 51. Generic Sterile Injectable Industrial Chain Analysis
    Figure 52. Channels of Distribution
    Figure 53. Distributors Profiles
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3350

This license allows only one user to access the PDF.
Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions